These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content. Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159 [TBL] [Abstract][Full Text] [Related]
5. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging. Li Y; Liu G; Lou X; Chen Z; Ma L Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511 [TBL] [Abstract][Full Text] [Related]
6. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
7. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA. Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439 [TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060 [TBL] [Abstract][Full Text] [Related]
9. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382 [TBL] [Abstract][Full Text] [Related]
10. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study. Mendichovszky IA; Cutajar M; Gordon I Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588 [TBL] [Abstract][Full Text] [Related]
11. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping. Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121 [TBL] [Abstract][Full Text] [Related]
12. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging. Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640 [TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA. Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476 [TBL] [Abstract][Full Text] [Related]
14. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
15. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery]. Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304 [TBL] [Abstract][Full Text] [Related]
16. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599 [TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images. Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats. Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051 [TBL] [Abstract][Full Text] [Related]
19. T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T. Lin K; Lloyd-Jones DM; Spottiswoode B; Bi X; Liu Y; Lu B; Xue H; Wang Y; Li D; Carr JC Invest Radiol; 2014 Apr; 49(4):243-8. PubMed ID: 24473364 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations. Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]